MNOV: Summary for MediciNova, Inc. - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, November 25, 2009, 12:32pm EST - Canadian Markets close in 3 hours and 28 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

MediciNova Inc. (MNOV)

At 11:06 EST: 6.25 USD

0.01 (0.16%)

MORE ON MNOV

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

MediciNova, Inc. (NGM:MNOV) Delayed quote data

Last Trade:	6.25 USD
Trade Time:	11:06AM EST
Change:	0.01 (0.16%)
Prev Close:	6.24
Open:	6.25
Bid:	6.25 x 300
Ask:	6.50 x 1000
1y Target Est:	12.50

Day's Range:	6.22 - 6.25
52wk Range:	1.40 - 7.46
Volume:	300
Avg Vol (3m):	6,183.33
Market Cap:	75.64M
P/E (ttm):	N/A
EPS (ttm):	-1.31
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y

Add MNOV to Portfolio

Download Data

HEADLINES

•	MEDICINOVA INC Financials
	EDGAR Online Financials (Wed, Nov 18)

•	MEDICINOVA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
	EDGAR Online (Tue, Nov 17)

•	MEDICINOVA INC Files SEC form 8-K, Regulation FD Disclosure
	EDGAR Online (Fri, Nov 13)

•	MEDICINOVA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
	EDGAR Online (Thu, Nov 12)

•	MEDICINOVA INC Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Thu, Nov 12)

•	MEDICINOVA INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
	EDGAR Online (Mon, Oct 5)

•	MEDICINOVA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
	EDGAR Online (Fri, Sep 25)

•	MEDICINOVA INC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Sta
	EDGAR Online (Wed, Sep 16)

•	MEDICINOVA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
	EDGAR Online (Fri, Sep 4)

•	MEDICINOVA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Other Events
	EDGAR Online (Mon, Aug 24)

More Headlines for MNOV...

ANALYST

EPS Est (next year) (Dec-09) :	-1.64
EPS Est (in 2 years) (Dec-10) :	-1.26
Avg Rec (current)*:	1.0
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

MediciNova, Inc., a biopharmaceutical company, engages in the acquisition and development of small molecule therapeutics for the treatment of diseases with unmet medical needs principally in the United States.

Full Company Profile

Add to Portfolio

Email to a Friend

•